Chemoinformaics analysis of 7,8-DIMETHOXY-9,10-DIHYDROPHENANTHRENE-2,4,6-TRIOL
| Molecular Weight | 288.299 | nRot | 2 |
| Heavy Atom Molecular Weight | 272.171 | nRig | 16 |
| Exact Molecular Weight | 288.1 | nRing | 3 |
| Solubility: LogS | -3.479 | nHRing | 0 |
| Solubility: LogP | 3.04 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 41.3987 |
| nHD | 3 | BPOL | 19.5233 |
| QED | 0.791 |
| Synth | 2.665 |
| Natural Product Likeliness | 1.861 |
| NR-PPAR-gamma | 0.904 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.087 |
| HIA | 0.007 |
| CACO-2 | -4.939 |
| MDCK | 0.0000137 |
| BBB | 0.035 |
| PPB | 0.961685 |
| VDSS | 0.566 |
| FU | 0.0533187 |
| CYP1A2-inh | 0.92 |
| CYP1A2-sub | 0.935 |
| CYP2c19-inh | 0.127 |
| CYP2c19-sub | 0.08 |
| CYP2c9-inh | 0.161 |
| CYP2c9-sub | 0.898 |
| CYP2d6-inh | 0.618 |
| CYP2d6-sub | 0.862 |
| CYP3a4-inh | 0.446 |
| CYP3a4-sub | 0.217 |
| CL | 8.912 |
| T12 | 0.744 |
| hERG | 0.21 |
| Ames | 0.386 |
| ROA | 0.146 |
| SkinSen | 0.887 |
| Carcinogencity | 0.022 |
| EI | 0.733 |
| Respiratory | 0.495 |
| NR-Aromatase | 0.722 |
| Antiviral | Yes |
| Prediction | 0.877291 |